HHM Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7K Hold
188
﹤0.01% 594
2026
Q1
$11.8K Buy
188
+136
+262% +$9.47K ﹤0.01% 609
2025
Q4
$3.45K Hold
52
﹤0.01% 741
2025
Q3
$3.5K Hold
52
﹤0.01% 757
2025
Q2
$4.54K Sell
52
-14
-21% -$1.1K ﹤0.01% 699
2025
Q1
$4.51K Hold
66
﹤0.01% 679
2024
Q4
$5.13K Buy
66
+14
+27% +$1.04K ﹤0.01% 679
2024
Q3
$3.49K Buy
+52
New +$4.27K ﹤0.01% 684
2023
Q2
Sell
-17
Closed -$1.98K 820
2023
Q1
$1.98K Hold
17
﹤0.01% 727
2022
Q4
$1.93K Buy
+17
New +$1.87K ﹤0.01% 612

Other funds holding DXCM

HHM Wealth Advisors's DXCM Position: Q2 2026 in Review

HHM Wealth Advisors held its DexCom (DXCM) position steady in Q2 2026 at 188 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #594.

HHM Wealth Advisors first reported a position in DXCM in Q4 2022 and has held it in 10 quarters since. 245 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • HHM Wealth Advisors held 188 shares of DexCom worth $12.7K as of Q2 2026.
  • HHM Wealth Advisors left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #594 holding.
  • HHM Wealth Advisors first reported a position in DexCom in Q4 2022 and has held it in 10 quarters since.
  • 245 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.